---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-23-000301"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2023-03-27T23:59:59+00:00"
generated_at: "2026-06-17T14:35:08.454640+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Lipella Pharmaceuticals appoints Daniel Cohen to Board and Audit Committee

## Summary
- Board appointed Daniel Cohen as director on March 21, 2023, expanding board to seven members.
- Cohen will serve until the next annual meeting and then stand for election.
- He was assigned to the Board's audit committee.
- No arrangements or understandings with any other persons regarding his appointment.
- Entered into no transactions requiring disclosure under Item 404(a).

## SEC filing metadata
- accession: 0001753926-23-000301
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2023-03-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392623000301/0001753926-23-000301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392623000301/g083458_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-23-000301
- JSON: https://secwatch.observer/filing/0001753926-23-000301.json
- Plain text: https://secwatch.observer/filing/0001753926-23-000301.txt

## Key facts
- Executive change
  Daniel Cohen was appointed as Director at LIPELLA PHARMACEUTICALS INC..
  - Action: appointed
  - Role: Director
  source text: On March 21, 2023, the board of directors (the “Board”) of Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company”), pursuant to its powers under the Company’s second amended and restated by-laws, appointed Daniel Cohen as a member of the Board, thereby increasing the Board membership count to seven (7).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1347242/000175392623000301/0001753926-23-000301-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.